Express Scripts Holding Revenue 2006-2018 | ESRX

Express Scripts Holding annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities.
  • Express Scripts Holding revenue for the quarter ending June 30, 2018 was $25.642B, a 1.16% increase year-over-year.
  • Express Scripts Holding revenue for the twelve months ending June 30, 2018 was $100.473B, a 0.2% increase year-over-year.
  • Express Scripts Holding annual revenue for 2017 was $100.065B, a 0.22% decline from 2016.
  • Express Scripts Holding annual revenue for 2016 was $100.288B, a 1.44% decline from 2015.
  • Express Scripts Holding annual revenue for 2015 was $101.752B, a 0.86% increase from 2014.
Express Scripts Holding Annual Revenue
(Millions of US $)
2017 $100,065
2016 $100,288
2015 $101,752
2014 $100,887
2013 $104,099
2012 $93,714
2011 $46,128
2010 $44,973
2009 $24,722
2008 $21,941
2007 $21,824
2006 $21,563
2005 $16,188
Express Scripts Holding Quarterly Revenue
(Millions of US $)
Q2 2018 $25,642
Q1 2018 $24,769
Q4 2017 $25,379
Q3 2017 $24,683
Q2 2017 $25,348
Q1 2017 $24,655
Q4 2016 $24,863
Q3 2016 $25,410
Q2 2016 $25,222
Q1 2016 $24,792
Q4 2015 $26,175
Q3 2015 $25,223
Q2 2015 $25,454
Q1 2015 $24,900
Q4 2014 $26,313
Q3 2014 $25,779
Q2 2014 $25,111
Q1 2014 $23,685
Q4 2013 $25,781
Q3 2013 $25,916
Q2 2013 $26,382
Q1 2013 $26,020
Q4 2012 $27,315
Q3 2012 $26,762
Q2 2012 $27,505
Q1 2012 $12,133
Q4 2011 $12,101
Q3 2011 $11,571
Q2 2011 $11,361
Q1 2011 $11,095
Q4 2010 $11,294
Q3 2010 $11,252
Q2 2010 $11,289
Q1 2010 $11,138
Q4 2009 $8,190
Q3 2009 $5,613
Q2 2009 $5,497
Q1 2009 $5,423
Q4 2008 $5,469
Q3 2008 $5,451
Q2 2008 $5,531
Q1 2008 $5,491
Q4 2007 $7,382
Q3 2007 $5,358
Q2 2007 $4,575
Q1 2007 $4,509
Q4 2006 $8,431
Q3 2006 $4,330
Q2 2006 $4,421
Q1 2006 $4,380
Q4 2005 $4,557
Q3 2005 $3,848
Q2 2005 $3,944
Q1 2005 $3,839
Sector Industry Market Cap Revenue
Medical Medical Services $53.424B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $8.112B 26.27
PRA Health Sciences (PRAH) United States $6.982B 30.47
Charles River Laboratories (CRL) United States $6.192B 22.62
HealthEquity (HQY) United States $5.773B 120.84
Premier (PINC) United States $5.701B 20.54
Teladoc (TDOC) United States $5.244B 0.00
INC Research Holdings (SYNH) United States $5.031B 22.33
NovoCure (NVCR) Jersey $4.571B 0.00
AMN Healthcare Services Inc (AMN) United States $2.436B 18.72
Medpace Holdings (MEDP) United States $2.076B 29.18
BioTelemetry (BEAT) United States $2.015B 46.20
Intrexon (XON) United States $1.879B 0.00
Natera (NTRA) United States $1.461B 0.00
Healthways (TVTY) United States $1.350B 19.07
IKang Healthcare (KANG) China $1.198B 66.35
CareDx (CDNA) United States $0.940B 0.00
Surgery Partners (SGRY) United States $0.790B 0.00
China Cord Blood (CO) China $0.788B 21.07
Apollo Medical Holdings (AMEH) United States $0.577B 0.00
Civitas Solutions (CIVI) United States $0.527B 10.39
Establishment Labs Holdings (ESTA) $0.484B 0.00
OncoCyte (OCX) United States $0.104B 0.00
Interpace Diagnostics (IDXG) United States $0.047B 0.00
Cancer Genetics (CGIX) United States $0.031B 0.00
OpGen (OPGN) United States $0.013B 0.00
Biocept (BIOC) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.004B 0.00